Global Pituitary Cancer Market Research Report 2023

Pituitary adenomas are tumors that occur in the pituitary gland. Pituitary adenomas are generally divided into three categories dependent upon their biological functioning: benign adenoma, invasive adenoma, and carcinomas. Most adenomas are benign, approximately 35% are invasive and just 0.1% to 0.2% are carcinomas. Pituitary adenomas represent from 10% to 25% of all intracranial neoplasms and the estimated prevalence rate in the general population is approximately 17%.

The global Pituitary Cancer market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

While pituitary adenomas are common, affecting approximately one in 6 of the general population, clinically active pituitary adenomas that require surgical treatment are more rare, affecting approximately one in 1000 of the general population.

This report aims to provide a comprehensive presentation of the global market for Pituitary Cancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pituitary Cancer.

The Pituitary Cancer market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Pituitary Cancer market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Pituitary Cancer companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Pituitary Cancer Market Size Growth Rate by Type: 2018 VS 2022 VS 2029

1.2.2 Blood Tests

1.2.3 Urine Test

1.2.4 Brain Imaging

1.2.5 Vision Testing

1.3 Market by Application

1.3.1 Global Pituitary Cancer Market Growth by Application: 2018 VS 2022 VS 2029

1.3.2 Hospital

1.3.3 Clinics

1.3.4 Diagnostic Centers

1.3.5 Research Institutes

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2.1 Global Pituitary Cancer Market Perspective (2018-2029)

2.2 Pituitary Cancer Growth Trends by Region

2.2.1 Global Pituitary Cancer Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Pituitary Cancer Historic Market Size by Region (2018-2023)

2.2.3 Pituitary Cancer Forecasted Market Size by Region (2024-2029)

2.3 Pituitary Cancer Market Dynamics

2.3.1 Pituitary Cancer Industry Trends

2.3.2 Pituitary Cancer Market Drivers

2.3.3 Pituitary Cancer Market Challenges

2.3.4 Pituitary Cancer Market Restraints

3.1 Global Top Pituitary Cancer Players by Revenue

3.1.1 Global Top Pituitary Cancer Players by Revenue (2018-2023)

3.1.2 Global Pituitary Cancer Revenue Market Share by Players (2018-2023)

3.2 Global Pituitary Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Pituitary Cancer Revenue

3.4 Global Pituitary Cancer Market Concentration Ratio

3.4.1 Global Pituitary Cancer Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Pituitary Cancer Revenue in 2022

3.5 Pituitary Cancer Key Players Head office and Area Served

3.6 Key Players Pituitary Cancer Product Solution and Service

3.7 Date of Enter into Pituitary Cancer Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Pituitary Cancer Historic Market Size by Type (2018-2023)

4.2 Global Pituitary Cancer Forecasted Market Size by Type (2024-2029)

5.1 Global Pituitary Cancer Historic Market Size by Application (2018-2023)

5.2 Global Pituitary Cancer Forecasted Market Size by Application (2024-2029)

6.1 North America Pituitary Cancer Market Size (2018-2029)

6.2 North America Pituitary Cancer Market Growth Rate by Country: 2018 VS 2022 VS 2029

6.3 North America Pituitary Cancer Market Size by Country (2018-2023)

6.4 North America Pituitary Cancer Market Size by Country (2024-2029)

6.5 United States

6.6 Canada

7.1 Europe Pituitary Cancer Market Size (2018-2029)

7.2 Europe Pituitary Cancer Market Growth Rate by Country: 2018 VS 2022 VS 2029

7.3 Europe Pituitary Cancer Market Size by Country (2018-2023)

7.4 Europe Pituitary Cancer Market Size by Country (2024-2029)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8.1 Asia-Pacific Pituitary Cancer Market Size (2018-2029)

8.2 Asia-Pacific Pituitary Cancer Market Growth Rate by Region: 2018 VS 2022 VS 2029

8.3 Asia-Pacific Pituitary Cancer Market Size by Region (2018-2023)

8.4 Asia-Pacific Pituitary Cancer Market Size by Region (2024-2029)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9.1 Latin America Pituitary Cancer Market Size (2018-2029)

9.2 Latin America Pituitary Cancer Market Growth Rate by Country: 2018 VS 2022 VS 2029

9.3 Latin America Pituitary Cancer Market Size by Country (2018-2023)

9.4 Latin America Pituitary Cancer Market Size by Country (2024-2029)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Pituitary Cancer Market Size (2018-2029)

10.2 Middle East & Africa Pituitary Cancer Market Growth Rate by Country: 2018 VS 2022 VS 2029

10.3 Middle East & Africa Pituitary Cancer Market Size by Country (2018-2023)

10.4 Middle East & Africa Pituitary Cancer Market Size by Country (2024-2029)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11.1 Trinity Biotech

11.1.1 Trinity Biotech Company Detail

11.1.2 Trinity Biotech Business Overview

11.1.3 Trinity Biotech Pituitary Cancer Introduction

11.1.4 Trinity Biotech Revenue in Pituitary Cancer Business (2018-2023)

11.1.5 Trinity Biotech Recent Development

11.2 Salzman

11.2.1 Salzman Company Detail

11.2.2 Salzman Business Overview

11.2.3 Salzman Pituitary Cancer Introduction

11.2.4 Salzman Revenue in Pituitary Cancer Business (2018-2023)

11.2.5 Salzman Recent Development

11.3 Genentech

11.3.1 Genentech Company Detail

11.3.2 Genentech Business Overview

11.3.3 Genentech Pituitary Cancer Introduction

11.3.4 Genentech Revenue in Pituitary Cancer Business (2018-2023)

11.3.5 Genentech Recent Development

11.4 Sigma-Aldrich

11.4.1 Sigma-Aldrich Company Detail

11.4.2 Sigma-Aldrich Business Overview

11.4.3 Sigma-Aldrich Pituitary Cancer Introduction

11.4.4 Sigma-Aldrich Revenue in Pituitary Cancer Business (2018-2023)

11.4.5 Sigma-Aldrich Recent Development

11.5 Varian Medical Systems

11.5.1 Varian Medical Systems Company Detail

11.5.2 Varian Medical Systems Business Overview

11.5.3 Varian Medical Systems Pituitary Cancer Introduction

11.5.4 Varian Medical Systems Revenue in Pituitary Cancer Business (2018-2023)

11.5.5 Varian Medical Systems Recent Development

11.6 Elekta

11.6.1 Elekta Company Detail

11.6.2 Elekta Business Overview

11.6.3 Elekta Pituitary Cancer Introduction

11.6.4 Elekta Revenue in Pituitary Cancer Business (2018-2023)

11.6.5 Elekta Recent Development

11.7 Accuray Incorporated

11.7.1 Accuray Incorporated Company Detail

11.7.2 Accuray Incorporated Business Overview

11.7.3 Accuray Incorporated Pituitary Cancer Introduction

11.7.4 Accuray Incorporated Revenue in Pituitary Cancer Business (2018-2023)

11.7.5 Accuray Incorporated Recent Development

11.8 Ion Beam Applications

11.8.1 Ion Beam Applications Company Detail

11.8.2 Ion Beam Applications Business Overview

11.8.3 Ion Beam Applications Pituitary Cancer Introduction

11.8.4 Ion Beam Applications Revenue in Pituitary Cancer Business (2018-2023)

11.8.5 Ion Beam Applications Recent Development

11.9 Nordion

11.9.1 Nordion Company Detail

11.9.2 Nordion Business Overview

11.9.3 Nordion Pituitary Cancer Introduction

11.9.4 Nordion Revenue in Pituitary Cancer Business (2018-2023)

11.9.5 Nordion Recent Development

11.10 Becton Dickinson

11.10.1 Becton Dickinson Company Detail

11.10.2 Becton Dickinson Business Overview

11.10.3 Becton Dickinson Pituitary Cancer Introduction

11.10.4 Becton Dickinson Revenue in Pituitary Cancer Business (2018-2023)

11.10.5 Becton Dickinson Recent Development

11.11 Isoray Medical

11.11.1 Isoray Medical Company Detail

11.11.2 Isoray Medical Business Overview

11.11.3 Isoray Medical Pituitary Cancer Introduction

11.11.4 Isoray Medical Revenue in Pituitary Cancer Business (2018-2023)

11.11.5 Isoray Medical Recent Development

11.12 RaySearch Laboratories

11.12.1 RaySearch Laboratories Company Detail

11.12.2 RaySearch Laboratories Business Overview

11.12.3 RaySearch Laboratories Pituitary Cancer Introduction

11.12.4 RaySearch Laboratories Revenue in Pituitary Cancer Business (2018-2023)

11.12.5 RaySearch Laboratories Recent Development

11.13 Mevion Medical Systems

11.13.1 Mevion Medical Systems Company Detail

11.13.2 Mevion Medical Systems Business Overview

11.13.3 Mevion Medical Systems Pituitary Cancer Introduction

11.13.4 Mevion Medical Systems Revenue in Pituitary Cancer Business (2018-2023)

11.13.5 Mevion Medical Systems Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Pituitary Cancer Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029

    Table 2. Key Players of Blood Tests

    Table 3. Key Players of Urine Test

    Table 4. Key Players of Brain Imaging

    Table 5. Key Players of Vision Testing

    Table 6. Global Pituitary Cancer Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029

    Table 7. Global Pituitary Cancer Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 8. Global Pituitary Cancer Market Size by Region (2018-2023) & (US$ Million)

    Table 9. Global Pituitary Cancer Market Share by Region (2018-2023)

    Table 10. Global Pituitary Cancer Forecasted Market Size by Region (2024-2029) & (US$ Million)

    Table 11. Global Pituitary Cancer Market Share by Region (2024-2029)

    Table 12. Pituitary Cancer Market Trends

    Table 13. Pituitary Cancer Market Drivers

    Table 14. Pituitary Cancer Market Challenges

    Table 15. Pituitary Cancer Market Restraints

    Table 16. Global Pituitary Cancer Revenue by Players (2018-2023) & (US$ Million)

    Table 17. Global Pituitary Cancer Market Share by Players (2018-2023)

    Table 18. Global Top Pituitary Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pituitary Cancer as of 2022)

    Table 19. Ranking of Global Top Pituitary Cancer Companies by Revenue (US$ Million) in 2022

    Table 20. Global 5 Largest Players Market Share by Pituitary Cancer Revenue (CR5 and HHI) & (2018-2023)

    Table 21. Key Players Headquarters and Area Served

    Table 22. Key Players Pituitary Cancer Product Solution and Service

    Table 23. Date of Enter into Pituitary Cancer Market

    Table 24. Mergers & Acquisitions, Expansion Plans

    Table 25. Global Pituitary Cancer Market Size by Type (2018-2023) & (US$ Million)

    Table 26. Global Pituitary Cancer Revenue Market Share by Type (2018-2023)

    Table 27. Global Pituitary Cancer Forecasted Market Size by Type (2024-2029) & (US$ Million)

    Table 28. Global Pituitary Cancer Revenue Market Share by Type (2024-2029)

    Table 29. Global Pituitary Cancer Market Size by Application (2018-2023) & (US$ Million)

    Table 30. Global Pituitary Cancer Revenue Market Share by Application (2018-2023)

    Table 31. Global Pituitary Cancer Forecasted Market Size by Application (2024-2029) & (US$ Million)

    Table 32. Global Pituitary Cancer Revenue Market Share by Application (2024-2029)

    Table 33. North America Pituitary Cancer Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 34. North America Pituitary Cancer Market Size by Country (2018-2023) & (US$ Million)

    Table 35. North America Pituitary Cancer Market Size by Country (2024-2029) & (US$ Million)

    Table 36. Europe Pituitary Cancer Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 37. Europe Pituitary Cancer Market Size by Country (2018-2023) & (US$ Million)

    Table 38. Europe Pituitary Cancer Market Size by Country (2024-2029) & (US$ Million)

    Table 39. Asia-Pacific Pituitary Cancer Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 40. Asia-Pacific Pituitary Cancer Market Size by Region (2018-2023) & (US$ Million)

    Table 41. Asia-Pacific Pituitary Cancer Market Size by Region (2024-2029) & (US$ Million)

    Table 42. Latin America Pituitary Cancer Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 43. Latin America Pituitary Cancer Market Size by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Pituitary Cancer Market Size by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Pituitary Cancer Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029

    Table 46. Middle East & Africa Pituitary Cancer Market Size by Country (2018-2023) & (US$ Million)

    Table 47. Middle East & Africa Pituitary Cancer Market Size by Country (2024-2029) & (US$ Million)

    Table 48. Trinity Biotech Company Detail

    Table 49. Trinity Biotech Business Overview

    Table 50. Trinity Biotech Pituitary Cancer Product

    Table 51. Trinity Biotech Revenue in Pituitary Cancer Business (2018-2023) & (US$ Million)

    Table 52. Trinity Biotech Recent Development

    Table 53. Salzman Company Detail

    Table 54. Salzman Business Overview

    Table 55. Salzman Pituitary Cancer Product

    Table 56. Salzman Revenue in Pituitary Cancer Business (2018-2023) & (US$ Million)

    Table 57. Salzman Recent Development

    Table 58. Genentech Company Detail

    Table 59. Genentech Business Overview

    Table 60. Genentech Pituitary Cancer Product

    Table 61. Genentech Revenue in Pituitary Cancer Business (2018-2023) & (US$ Million)

    Table 62. Genentech Recent Development

    Table 63. Sigma-Aldrich Company Detail

    Table 64. Sigma-Aldrich Business Overview

    Table 65. Sigma-Aldrich Pituitary Cancer Product

    Table 66. Sigma-Aldrich Revenue in Pituitary Cancer Business (2018-2023) & (US$ Million)

    Table 67. Sigma-Aldrich Recent Development

    Table 68. Varian Medical Systems Company Detail

    Table 69. Varian Medical Systems Business Overview

    Table 70. Varian Medical Systems Pituitary Cancer Product

    Table 71. Varian Medical Systems Revenue in Pituitary Cancer Business (2018-2023) & (US$ Million)

    Table 72. Varian Medical Systems Recent Development

    Table 73. Elekta Company Detail

    Table 74. Elekta Business Overview

    Table 75. Elekta Pituitary Cancer Product

    Table 76. Elekta Revenue in Pituitary Cancer Business (2018-2023) & (US$ Million)

    Table 77. Elekta Recent Development

    Table 78. Accuray Incorporated Company Detail

    Table 79. Accuray Incorporated Business Overview

    Table 80. Accuray Incorporated Pituitary Cancer Product

    Table 81. Accuray Incorporated Revenue in Pituitary Cancer Business (2018-2023) & (US$ Million)

    Table 82. Accuray Incorporated Recent Development

    Table 83. Ion Beam Applications Company Detail

    Table 84. Ion Beam Applications Business Overview

    Table 85. Ion Beam Applications Pituitary Cancer Product

    Table 86. Ion Beam Applications Revenue in Pituitary Cancer Business (2018-2023) & (US$ Million)

    Table 87. Ion Beam Applications Recent Development

    Table 88. Nordion Company Detail

    Table 89. Nordion Business Overview

    Table 90. Nordion Pituitary Cancer Product

    Table 91. Nordion Revenue in Pituitary Cancer Business (2018-2023) & (US$ Million)

    Table 92. Nordion Recent Development

    Table 93. Becton Dickinson Company Detail

    Table 94. Becton Dickinson Business Overview

    Table 95. Becton Dickinson Pituitary Cancer Product

    Table 96. Becton Dickinson Revenue in Pituitary Cancer Business (2018-2023) & (US$ Million)

    Table 97. Becton Dickinson Recent Development

    Table 98. Isoray Medical Company Detail

    Table 99. Isoray Medical Business Overview

    Table 100. Isoray Medical Pituitary Cancer Product

    Table 101. Isoray Medical Revenue in Pituitary Cancer Business (2018-2023) & (US$ Million)

    Table 102. Isoray Medical Recent Development

    Table 103. RaySearch Laboratories Company Detail

    Table 104. RaySearch Laboratories Business Overview

    Table 105. RaySearch Laboratories Pituitary Cancer Product

    Table 106. RaySearch Laboratories Revenue in Pituitary Cancer Business (2018-2023) & (US$ Million)

    Table 107. RaySearch Laboratories Recent Development

    Table 108. Mevion Medical Systems Company Detail

    Table 109. Mevion Medical Systems Business Overview

    Table 110. Mevion Medical Systems Pituitary Cancer Product

    Table 111. Mevion Medical Systems Revenue in Pituitary Cancer Business (2018-2023) & (US$ Million)

    Table 112. Mevion Medical Systems Recent Development

    Table 113. Research Programs/Design for This Report

    Table 114. Key Data Information from Secondary Sources

    Table 115. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Pituitary Cancer Market Size Comparison by Type (2023-2029) & (US$ Million)

    Figure 2. Global Pituitary Cancer Market Share by Type: 2022 VS 2029

    Figure 3. Blood Tests Features

    Figure 4. Urine Test Features

    Figure 5. Brain Imaging Features

    Figure 6. Vision Testing Features

    Figure 7. Global Pituitary Cancer Market Size Comparison by Application (2023-2029) & (US$ Million)

    Figure 8. Global Pituitary Cancer Market Share by Application: 2022 VS 2029

    Figure 9. Hospital Case Studies

    Figure 10. Clinics Case Studies

    Figure 11. Diagnostic Centers Case Studies

    Figure 12. Research Institutes Case Studies

    Figure 13. Pituitary Cancer Report Years Considered

    Figure 14. Global Pituitary Cancer Market Size (US$ Million), Year-over-Year: 2018-2029

    Figure 15. Global Pituitary Cancer Market Size, (US$ Million), 2018 VS 2022 VS 2029

    Figure 16. Global Pituitary Cancer Market Share by Region: 2022 VS 2029

    Figure 17. Global Pituitary Cancer Market Share by Players in 2022

    Figure 18. Global Top Pituitary Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pituitary Cancer as of 2022)

    Figure 19. The Top 10 and 5 Players Market Share by Pituitary Cancer Revenue in 2022

    Figure 20. North America Pituitary Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 21. North America Pituitary Cancer Market Share by Country (2018-2029)

    Figure 22. United States Pituitary Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 23. Canada Pituitary Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 24. Europe Pituitary Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 25. Europe Pituitary Cancer Market Share by Country (2018-2029)

    Figure 26. Germany Pituitary Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 27. France Pituitary Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 28. U.K. Pituitary Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 29. Italy Pituitary Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 30. Russia Pituitary Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 31. Nordic Countries Pituitary Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 32. Asia-Pacific Pituitary Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 33. Asia-Pacific Pituitary Cancer Market Share by Region (2018-2029)

    Figure 34. China Pituitary Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 35. Japan Pituitary Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 36. South Korea Pituitary Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 37. Southeast Asia Pituitary Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 38. India Pituitary Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 39. Australia Pituitary Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 40. Latin America Pituitary Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 41. Latin America Pituitary Cancer Market Share by Country (2018-2029)

    Figure 42. Mexico Pituitary Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 43. Brazil Pituitary Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 44. Middle East & Africa Pituitary Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 45. Middle East & Africa Pituitary Cancer Market Share by Country (2018-2029)

    Figure 46. Turkey Pituitary Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 47. Saudi Arabia Pituitary Cancer Market Size YoY Growth (2018-2029) & (US$ Million)

    Figure 48. Trinity Biotech Revenue Growth Rate in Pituitary Cancer Business (2018-2023)

    Figure 49. Salzman Revenue Growth Rate in Pituitary Cancer Business (2018-2023)

    Figure 50. Genentech Revenue Growth Rate in Pituitary Cancer Business (2018-2023)

    Figure 51. Sigma-Aldrich Revenue Growth Rate in Pituitary Cancer Business (2018-2023)

    Figure 52. Varian Medical Systems Revenue Growth Rate in Pituitary Cancer Business (2018-2023)

    Figure 53. Elekta Revenue Growth Rate in Pituitary Cancer Business (2018-2023)

    Figure 54. Accuray Incorporated Revenue Growth Rate in Pituitary Cancer Business (2018-2023)

    Figure 55. Ion Beam Applications Revenue Growth Rate in Pituitary Cancer Business (2018-2023)

    Figure 56. Nordion Revenue Growth Rate in Pituitary Cancer Business (2018-2023)

    Figure 57. Becton Dickinson Revenue Growth Rate in Pituitary Cancer Business (2018-2023)

    Figure 58. Isoray Medical Revenue Growth Rate in Pituitary Cancer Business (2018-2023)

    Figure 59. RaySearch Laboratories Revenue Growth Rate in Pituitary Cancer Business (2018-2023)

    Figure 60. Mevion Medical Systems Revenue Growth Rate in Pituitary Cancer Business (2018-2023)

    Figure 61. Bottom-up and Top-down Approaches for This Report

    Figure 62. Data Triangulation

    Figure 63. Key Executives Interviewed